Blueprint Genetics
Sari Tuupanen is a seasoned genetics professional with extensive experience in both academic and clinical settings. Currently serving as Genetics Director at Blueprint Genetics since June 2015, Sari has progressed through various roles including Senior Geneticist and Senior Manager of Clinical Interpretation. Sari's academic background includes a Ph.D. and an M.Sc. in Genetics from the University of Helsinki, with a research focus on cancer genetics. Prior to joining Blueprint Genetics, Sari held positions at the University of Helsinki, Johns Hopkins University, and the Hospital District of Helsinki and Uusimaa, contributing to significant advancements in genetic research and interpretation.
This person is not in any teams
This person is not in any offices
Blueprint Genetics
Blueprint Genetics provides genetic diagnostics of rare diseases based on Next-Generation Sequencing (NGS).The professional genetic tests are targeted for hospitals and research groups. Blueprint Genetics aims to disrupt the market by decreasing the price level of genetic diagnostics significantly while increasing quality and adding clinicalinsight to the results statements.The tests are based on a novel NGS method called OS-Seq:tm: that was developed in the Stanford University.The product roadmap of the company covers a long list of diagnostics for different hereditary diseases. The currently available products cover relevant rare hereditary cardiovascular diseases, such as cardiomyopathies, arrhythmias and aorta diseases.The company is based in Helsinki, Finland and has an office also in Los Angeles, CA.